FDA Inspection
Calyx Chemicals & Pharmaceuticals LimitedCalyx Chemicals & Pharmaceuticals Limited – FDA Inspection, Mar 4, 2016
Record Details
This FDA Inspection record concerns Calyx Chemicals & Pharmaceuticals Limited, with an inspection on March 4, 2016, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- March 4, 2016
- Product Type
- Drugs
View Company Profile
ID · f179bf14-ab8e-4879-a384-b878e09ae5c0
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 967429
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Calyx Chemicals & Pharmaceuticals Limited
4| Date | Classification | Office | Project area |
|---|---|---|---|
| May 17, 2024 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 8, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 27, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 18, 2009 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Calyx Chemicals & Pharmaceuticals Limited
- FDA Inspection 1240456 - 2024-05-17
- FDA Inspection 1110153 - 2019-11-08
- FDA Inspection 775620 - 2012-03-27
- FDA Inspection 641001 - 2009-09-18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.